Multidisciplinary International Forum on Extracorporeal Diagnosis of Gastroesophageal Reflux and the launch meeting of peptest
On September 6, 2019, the launch of the Multidisciplinary International Forum in the Field of Gastroesophageal Reflux External Diagnosis and the Salivary Pepsin Reflux Detection Reagent Peptest was successfully concluded in Beijing.
Wu Jimin, President of the General Assembly and Director of Gastroesophageal Reflux Disease Department of the Chinese People's Liberation Army Characteristic Medical Center, delivered a speech at the meeting. Mr. Mark Watson, Academician of the Royal College of Surgery, Mr. Takemoto, Center for Digestive Endoscopy, Sayono Hospital, Japan, Professor Zou Duowu, Center for Digestive Endoscopy, Ruijin Hospital, Medical College of Shanghai Jiaotong University, Professor Wang Bangmao, General Hospital of Tianjin Medical University, Professor Zhang Yunjian, Jishuitan Hospital, Beijing, Professor Professor Wang Zhifei of Zhejiang People's Hospital attended the conference as an invited expert. At the same time, many experts from the national gastroesophageal reflux disease and related fields attended the conference.
Because the clinical manifestations of gastroesophageal reflux are complex and lack of specificity, many patients are atypical, and the existing diagnostic methods have some limitations. Sometimes, patients often go to many hospital departments to see a doctor. It is difficult to diagnose in time, which will indeed bring various troubles to patients.
Repeated cough, asthma, chronic pharyngitis, rhinitis, otitis media and other symptoms or diseases may be caused by gastroesophageal reflux disease.
At this conference, Peptest, the first pepsin reflux detection reagent to enter China, is the first non-invasive in vitro diagnostic reagent for esophageal reflux disease in the world. It can quickly and safely diagnose reflux and reflux-related respiratory tract, ear, nose and throat diseases. It is easy to use, simple to operate and accurate to diagnose reflux and related diseases. Peptest, introduced by Mei'an Medicine, is of great significance for the rapid diagnosis of gastroesophageal reflux disease, and also brings more convenience to patients who are troubled by related diseases. Compared with conventional diagnostic methods, it is not only more economical, but also simpler and completely non-invasive.
)RD Biomed Ltd CEO Harvey Dettmar Presentation of salivary pepsinase detection reagents for experts and guests present)
(Doncaster Royal Infirmary Mark Watson Application of Salivary Pepsin Detection in Diagnosis of Reflux Diseases)
(On-site experts are discussing the current situation of patients with gastroesophageal reflux disease in various departments)
(Launching Ceremony of Peptest, a Salivary Pepsin Reflux Detection Reagent for Maxhealth Medical Group China)